TY - JOUR T1 - COVID-19 Enfeksiyonu ve Gebelik Üzerindeki Etkileri TT - COVID-19 Infectıon and Its Effects on Pregnancy AU - Özcan, Handan AU - Elkoca, Ayşe AU - Yalçın, Önay PY - 2020 DA - March Y2 - 2020 DO - 10.21673/anadoluklin.708151 JF - Anatolian Clinic the Journal of Medical Sciences JO - Anatolian Clin PB - Hayat Sağlık ve Sosyal Hizmetler Vakfı WT - DergiPark SN - 2149-5254 SP - 43 EP - 50 VL - 25 IS - Special Issue on COVID 19 LA - tr AB - Çin’de aralık ayında görülen ve pandemi olarak ilanedilen COVID-19 enfeksiyonu ile ilgili her geçen gün morbidite ve mortaliteoranları yükselmektedir. Salgın ile beraber gebelik süreciyle ilgili kaygılar daartmaktadır. COVID-19 pnömonisi geçiren gebeler ile genel popülasyonun klinik belirtileribenzerdir. Gebelerin solunum patojenlerine ve şiddetli pnömoniye karşı dahahassas olması ve yapılan çalışmalarda vaka sayılarının azlığı sebebi ilesürecin daha kontrollü sürdürülmesi gerekmektedir. Dünya sağlık örgütütarafından önerilen Enfeksiyonu Önleme ve Kontrol (IPC) basamaklarının gebelerde olduğu gibidüşük, fetal kayıp, postpartum dönemdeki kadınlar ve bebek bakımını üstlenenkişiler tarafından da uygulanması gerektiği vurgulanmıştır. Yapılançalışmalarda yeterli kanıtlar olmamakla beraber hastalığın anneden bebeğe geçişinindikey bulaşla olduğu belirtilmiştir. Enfeksiyon veya şüphesi olan gebelerindoğumdan sonra en az 14 gün boyunca bebeği ile yakın temasının kesilmesi veemzirilmemesi önerilmektedir. Doğum şekli için tıbbi bir endikasyon yoksavajinal yolla yapılabileceği belirtilmektedir.Gebeler enfeksiyon sürecinde perinatoloji, yenidoğanve yoğun bakım uzmanlarından oluşan multidisipliner bir yaklaşımla elealınmalıdır. Ayrıca bu süreçte gebelere psikososyal desteğin sağlanması da çokönemlidir. KW - Koronavirüs KW - pandemi KW - gebelik N2 - Morbidity and mortality rates are increasing day byday in relation to the COVID-19 infection seen in China in December andannounced as a pandemic. Concerns about the pregnancy process increase with theepidemic. The clinical manifestations of the general population are similar tothose of pregnant women who have had COVID-19 pneumonia. Because the pregnantwomen are more sensitive to respiratory pathogens and severe pneumonia, theprocess should be maintained in a more controlled manner due to the low numberof cases. It was emphasized that the IPC measures proposed by the world healthorganization should be implemented by pregnant women, as well as those in abortus,fetal loss, postpartum period, and those who take care of the baby. Althoughthere is not enough evidence in the studies conducted, it was stated that thetransition of the disease from mother to baby is by vertical transmission. Itis recommended that pregnant women with infection or suspicion should not bekept in close contact with their baby for at least 14 days after birth and notbreastfeeding. It is stated that if there is no medical indication fordelivery, it can be done vaginally.Pregnant women should be handled with amultidisciplinary approach consisting of obstetric, perinatal, newborn andintensive care specialists during the infection process. Also, providingpsychosocial support to pregnant women is very important in this process. CR - KAYNAKLAR CR - 1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. CR - 2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China Novel Coronavirus, I., Research, T.(2020) A Novel Coronavirus from Patients with Pneumonia in China, N Engl J Med. 2019. CR - 3. Novel CPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi. 2020;41(2):145. CR - 4. Dhama K, Sharun K, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019–COVID-19. 2020. CR - 5. Organization WH. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, Switzerland. 2005. CR - 6. Chan JF-W, To KK-W, Tse H, Jin D-Y, Yuen K-Y. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends in microbiology. 2013;21(10):544-55. CR - 7. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology. 2020. CR - 8. Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020:200463. CR - 9. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? International Journal of Epidemiology. 2020. CR - 10. McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19). CR - 11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020. CR - 12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. CR - 13. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Jama. 2020. CR - 14. Boldog P, Tekeli T, Vizi Z, Dénes A, Bartha FA, Röst G. Risk assessment of novel coronavirus COVID-19 outbreaks outside China. Journal of Clinical Medicine. 2020;9(2):571. CR - 15. Xu H, Huang S, Liu S, Deng J, Jiao B, Ai L, et al. Evaluation of the clinical characteristics of suspected or confirmed cases of COVID-19 during home care with isolation: A new retrospective analysis based on O2O. Available at SSRN 3548746. 2020. CR - 16. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020. CR - 17. Li X, Hu C, Su F, Dai J. Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19). medRxiv. 2020. CR - 18. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC. 2020. CR - 19. Gottfredsson M. The Spanish flu in Iceland 1918. Lessons in medicine and history. Laeknabladid. 2008;94(11):737-45. CR - 20. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. American journal of obstetrics and gynecology. 2004;191(1):292-7. CR - 21. Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virology journal. 2019;16(1):69. CR - 22. Zhang Y. Novel 2019 coronavirus genome. Virological.[Accessed 21 Jan 2020]. CR - 23. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;395(10226):809-15. CR - 24. Zhelezov D, Kossey T, Zarzhitskaya N. Features of myometrium remodeling after surgical inteventions on the uterus. Journal of Education, Health and Sport. 2020;10(1):142-9. CR - 25. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020. CR - 26. Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020. CR - 27. Qiao J. What are the risks of COVID-19 infection in pregnant women? The Lancet. 2020;395(10226):760-2. CR - 28. ACOG. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel CCoronaries (COVID-19) 2020. UR - https://doi.org/10.21673/anadoluklin.708151 L1 - https://dergipark.org.tr/en/download/article-file/1027052 ER -